AzTrials
AzTrials

Air Leak From LungNCT03021369

Comparison of Two Different Pleural Drainage Systems

A study testing Pleural drainage system in people with Air Leak From Lung, run by Kerckhoff Klinik at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The digital pleural drainage system Topaz+ by Medela is compared to the analogue system Atrium OCEAN by Maquet in patients undergoing cardiac surgery. The study is prospectively randomized with an all-comer setup. The patients are randomly selected for one of the systems. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Air Leak From Lung
What is being tested?
Pleural drainage system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
374 participants
Where
1 siteGermany
Study dates
Sep 2016to Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patients undergoing cardiac surgery
  • capability to give informed consent

Who cannot join

  • no specific exclusion criteria

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Kerckhoff Klinik

    Bad Nauheim, 61231

Other trials in Germany

About this study

Official title: Vergleich Zweier Thoraxdrainage-Systeme in Der Herzchirurgie

The digital pleural drainage system Topaz+ by Medela is compared to the analogue system Atrium OCEAN by Maquet in patients undergoing cardiac surgery.

The study is prospectively randomized with an all-comer setup. The patients are randomly selected for one of the systems. The surgery is performed in the standard fashion and chest tubes are placed routinely by the surgeon depending on the type of surgery. A retrosternal 32 French drain is placed in every patient and pericardial and/or pleural drains are optional.

The postoperative course does not vary from the clinical standard and the chest tubes are removed according to institutional standard. The clinical data about fluid amount, time of removal, air leaks, tamponade are routinely collected in a digital patient documentation system.

Being tested
Pleural drainage system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pleural drainage systemDevice

    Pleural drainage system is connected to the chest tubes after surgery.

Study groups in NCT03021369
Study groupRoleWhat they receive
Pleural drainage system MedelaActive comparatorThese patients receive the digital Medela system
Receives: Device: Pleural drainage system
Pleural drainage system OceanActive comparatorThese patients receive the analogue Maquet system
Receives: Device: Pleural drainage system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Detection of air leak due to lung leakage or injury during surgery by the pleural drainage system.

    The Thopaz+ system displays the amount of air leak on the screen in ml/min and the Ocean system is a 'wet seal' system, where bubbles in the box might indicate an air leak. If air leak is detected, the train cannot be removed and has to stay until no more air leak is detected. If air leak is unclear, chest x-rays with clamped drains are performed. If an pneumothorax is visible in the x-ray, the drains have to stay, otherwise they can be removed safely. The digital air leak detection and quantification by the Thopaz+ system might help in clearly detecting the air leaks.

    Measured: Occurrence of air leak is until the drain is removed (usually postoperative day 2 or 3)

Secondary outcomes (4)
  1. Time of chest drain removal

    Measured: Number of days until the chest drains are removed (usually postoperative day 2 or 3, depending on air leak and amount of fluid).

  2. Fluid amount

    Measured: Total amount of fluid at the time of chest drain removal (usually postoperative day 2 or 3, depending on air leak and amount of fluid).

  3. Number of patients with pericardial tamponade that has to be treated by puncture or surgically

    Measured: Occurrence through hospital stay (an average of 1 week).

  4. Number of patients with pleural effusion at discharge echo, without intervention

    Measured: Occurrence through hospital stay (an average of 1 week).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2017 (estimated)
  2. Study startSep 2016
  3. Primary completionDec 2017
  4. Study completionMar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
374 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03021369
Sponsor's protocol ID
Medela1
Status last verified
Feb 2020
First submitted
8 Jan 2017
Last updated
25 Feb 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Pleural drainage system in people with Air Leak From Lung, run by Kerckhoff Klinik at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Detection of air leak due to lung leakage or injury during surgery by the pleural drainage system. (time frame: Occurrence of air leak is until the drain is removed (usually postoperative day 2 or 3)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in